# University of Malawi

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-malawi/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 49.7 |
| Citations | 521,245 |
| City | Zomba |
| Country | MW |
| Description | University of Malawi is a research organisation in Zomba, MW. OpenAlex records 13,008 works and 521,245 citations for it. 2,520 researchers list it as their most recent affiliation. |
| Homepage | http://www.unima.mw/ |
| OpenAlex ID | https://openalex.org/I157591606 |
| Region | Nkhotakota |
| Researchers | 2,520 |
| ROR ID | https://ror.org/04vtx5s55 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q671642 |
| Works | 13,008 |

## University papers

Showing 12 of 26.

- [Final Version of 2009 AJCC Melanoma Staging and Classification](https://scholariq.org/papers/final-version-of-2009-ajcc-melanoma-staging-and-classification/)
- [Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma](https://scholariq.org/papers/final-version-of-the-american-joint-committee-on-cancer-staging-system-for/)
- [Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System](https://scholariq.org/papers/prognostic-factors-analysis-of-17-600-melanoma-patients-validation-of-the/)
- [High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190](https://scholariq.org/papers/high-and-low-dose-interferon-alfa-2b-in-high-risk-melanoma-first-analysis-of/)
- [Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma](https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/)
- [Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials](https://scholariq.org/papers/meta-analysis-of-phase-ii-cooperative-group-trials-in-metastatic-stage-iv/)
- [Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma](https://scholariq.org/papers/development-of-metastatic-disease-after-enrollment-in-the-coms-trials-for/)
- [A new American Joint Committee on Cancer staging system for cutaneous melanoma](https://scholariq.org/papers/a-new-american-joint-committee-on-cancer-staging-system-for-cutaneous-melanoma/)
- [Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases](https://scholariq.org/papers/multivariate-analysis-of-prognostic-factors-among-2-313-patients-with-stage-iii/)
- [Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study](https://scholariq.org/papers/efficacy-and-safety-of-lifileucel-a-one-time-autologous-tumor-infiltrating/)
- [Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/three-year-overall-survival-with-tebentafusp-in-metastatic-uveal-melanoma/)

## University researchers

- [Blessings N. Kaunda-Khangamwa](https://scholariq.org/researchers/blessings-n-kaunda-khangamwa/)
- [Chikondi Masamba Makanani](https://scholariq.org/researchers/chikondi-masamba-makanani/)

## University top topics

Showing 8 of 25.

- [Global Maternal and Child Health](https://scholariq.org/topics/global-maternal-and-child-health/)
- [Malaria Research and Control](https://scholariq.org/topics/malaria-research-and-control/)
- [Child Nutrition and Water Access](https://scholariq.org/topics/child-nutrition-and-water-access/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [Adolescent Sexual and Reproductive Health](https://scholariq.org/topics/adolescent-sexual-and-reproductive-health/)
- [Global Health and Surgery](https://scholariq.org/topics/global-health-and-surgery/)
- [Parasites and Host Interactions](https://scholariq.org/topics/parasites-and-host-interactions/)
- [Mosquito-borne diseases and control](https://scholariq.org/topics/mosquito-borne-diseases-and-control/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.